openPR Logo
Press release

Atrial Fibrillation (AF) Ablation Market Value Chain and Forecast 2018 to 2028(Based on product type, the global atrial fibrillation ablation market is segmented as: Cryoablation Probes and Pens Radiofrequency Clamps Temperature controlled radiofrequency

05-20-2019 09:40 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Atrial Fibrillation (AF) Ablation Market Value Chain

Arterial fibrillation is a disease that creates irregular and rapid heart rate. Atrial fibrillation ablation is performed to treat the disease. The upper chambers of the heart beat irregularly and contract randomly at a very fast rate, out of coordination with the lower ventricles of the heart due to which the time decreases for the heart muscle relaxation. This increases the rate of heart failure and heart strokes and reduces the efficiency and performance of the heart. The symptoms for atrial fibrillation include weakness, heart palpitations, and shortness of breath. The irregular impulses revoke the heart’s natural pacemaker and cannot control the rhythm of the heart. In normal conditions, the heart beats 60–100 times per minute while in case of atrial fibrillation the heart beat changes to about 100–175 beats per minute which is cured by atrial fibrillation ablation.

Atrial Fibrillation (AF) Ablation Market: Drivers and Restraints

The growing prevalence of coronary heart disease, cardiac diseases such as heart attacks, strokes, high blood pressure, previous heart surgeries is expected to be the major factor driving the growth of the atrial fibrillation ablation market. According to the Center for Disease Control and Prevention (CDC) an estimated of 2.7–6.1 million people are suffering from atrial fibrillation in the U.S. Moreover, almost 750,000 hospitalizations occur every year due to atrial fibrillation which is creating growth opportunities for the atrial fibrillation ablation market. This condition contributes to an estimated 130,000 deaths. Some of the risk factors for atrial fibrillation include increasing age, obesity, diabetes, chronic kidney disease and excessive intake of alcohol. New devices and technologies are being developed for the atrial fibrillation ablation which control the heart rhythms caused by abnormal signals to help patients survive. These devices with minimal invasion provide rapid results and greater efficiency and are used where medications fail. The catheters used for atrial fibrillation ablation provide energy to create an abrasion, which aborts the abnormal electric signals.

Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=2269

Atrial Fibrillation (AF) Ablation Market: Segmentation

Tentatively, the global atrial fibrillation ablation market can be segmented on the basis of product type, technology and end users.

Based on product type, the global atrial fibrillation ablation market is segmented as:

Cryoablation Probes and Pens
Radiofrequency Clamps
Temperature controlled radiofrequency Ablators
Radiofrequency ablation catheters
Based on technology, the global atrial fibrillation ablation market is segmented as:

Radiofrequency energy
Cryoablation
Based on end users, the global atrial fibrillation ablation market is segmented as:

Hospitals
Super specialty clinics
Atrial Fibrillation Ablation Market: Overview

Atrial fibrillation ablation is a technique in which the irregular and out-of-synchronized electric signals are treated. For atrial fibrillation ablation two types of technologies are used, i.e., radiofrequency energy and cryoablation. The cryoballon delivers a refrigerant. The tip of the catheters are advanced into the vein which when reach the target freeze the tissue which is in contact with the balloon. While in case of radio frequency energy, heat is passed around the pulmonary veins to create a circular scar which in return will reduce the frequency of atrial fibrillation. The global market of atrial fibrillation is expected to witness high growth over the forecast period. With the advancement of technology, majority of the devices are introduced in the market which generate competition among the local as well as regional players. The market for atrial fibrillation ablation is expected to increase with the rise in the cardiac diseases. The geriatric population is expected to be affected the most.

Atrial Fibrillation (AF) Ablation Market: Regional Outlook

Geographically, the global atrial fibrillation ablation market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be dominant regional market for atrial fibrillation ablation owing to increasing risk factors such as increasing age, obesity diabetes resulting in cardiac diseases. Also the market in North America will rise due to the advancement in the technology and products, strict regulations for patient care and safety in the region. The atrial fibrillation ablation market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to increasing geriatric population opting for atrial fibrillation ablation procedures to avoid blood clots and strokes causing death of the patient. In addition, initiatives by the governments in the region on providing better healthcare facilities to the population contribute to the growth of the atrial fibrillation ablation market. Europe is expected to have second large share in the global atrial fibrillation ablation market throughout the forecast period.

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=2269

Atrial Fibrillation (AF) ablation Market: Key Players

The global market for atrial fibrillation ablation is highly fragmented. Examples of some of the key players operating in the global atrial fibrillation ablation market are Boston Scientific Corporation, Medtronic, AtriCure, Inc. LuxCath LLC, BIOTRONIK UK Ltd, Biosense Webster, Inc, MicroPort Scientific Corporation, Baylis Medical Company, Inc and Lepu (Beijing) Medical Devices Co., Ltd. and AFreeze, among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America
US
Canada
Latin America
Brazil
Mexico
Argentina
Chile
Peru
Rest of LatAm
Europe
EU – 4 (Germany, France, Italy, Spain)
UK
BENELUX (Belgium, Netherlands, Luxemburg)
NORDIC (Norway, Denmark, Iceland, Sweden)
Eastern Europe (Poland, Ukraine, Czech Rep. etc.)
Rest of Europe
CIS & Russia
Japan
APEJ
Greater China
India
Korea
ASEAN Countries
Rest of APEJ
Middle East & Africa
GCC Countries
Turkey
Iran
Israel
South Africa
Rest of MEA
Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Report Analysis@ https://www.factmr.com/report/2269/atrial-fibrillation-ablation-market

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atrial Fibrillation (AF) Ablation Market Value Chain and Forecast 2018 to 2028(Based on product type, the global atrial fibrillation ablation market is segmented as: Cryoablation Probes and Pens Radiofrequency Clamps Temperature controlled radiofrequency here

News-ID: 1744920 • Views:

More Releases from Fact.MR

Bagless Vacuum Cleaners Market Is Predicted To Touch US$ 39.52 Billion By 2033: Fact.MR Report
Bagless Vacuum Cleaners Market Is Predicted To Touch US$ 39.52 Billion By 2033: …
The global demand for bagless vacuum cleaners is forecasted to experience a compound annual growth rate (CAGR) of 8% from 2023 to 2033. Consequently, the market for bagless vacuum cleaners worldwide is anticipated to surge from a value of US$ 18.3 billion in 2023 to reach US$ 39.52 billion by the end of 2033. The Bagless Vacuum Cleaner Industry sales study offers a comprehensive analysis on diverse features including production
NFC Chips Are Predicted To Reach US$ 7.6 Billion At A CAGR Of 15% By 2033: Fact.MR Report
NFC Chips Are Predicted To Reach US$ 7.6 Billion At A CAGR Of 15% By 2033: Fact. …
The global NFC chip market is valued at US$ 1.9 billion in 2023 and is forecasted to surge at a CAGR of 15% to reach a market size of US$ 7.6 billion by the end of 2033. The NFC Chip Industry sales study offers a comprehensive analysis on diverse features including production capacities, NFC Chip demand, product developments, sales revenue generation and NFC Chip market outlook across the globe. market research
Canned Beans Market Is Anticipated To Reach US$ 15 Billion By 2033: Fact.MR Report
Canned Beans Market Is Anticipated To Reach US$ 15 Billion By 2033: Fact.MR Repo …
The global canned beans market is valued at US$ 5.65 billion in 2023 and is projected to reach US$ 15 billion by the end of 2033, expanding at a high-value CAGR of 10.3% from 2023 to 2033. The Canned Beans Industry sales study offers a comprehensive analysis on diverse features including production capacities, Canned Beans demand, product developments, sales revenue generation and Canned Beans market outlook across the globe. market research
Plasma Fractionation Market Projected to Reach US$ 65 Billion by 2032, With 7.3% CAGR | Fact.MR
04-25-2024 | Health & Medicine
Fact.MR
Plasma Fractionation Market Projected to Reach US$ 65 Billion by 2032, With 7.3% …
The plasma fractionation market is projected to be valued US$ 32 billion in 2022. Moreover, growth is anticipated to pick up speed at a 7.3% CAGR over the assessment period of 2022-2032 and reach US$ 65 billion. The primary driver of the market's growth is the aging of the global population, which makes people more vulnerable to rare illnesses that call for the usage of blood derivatives. Furthermore, it is anticipated

All 5 Releases


More Releases for Atrial

Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Atrial Fibrillation Market
Atrial Fibrillation Market is predicted to grow at a double digit CAGR over the forecast period (2017 to 2023). Atrial fibrillation, also denoted as AF, is an irregular or fast heart rhythm. It raises the dangers of chest pain, heart strokes, congestive heart failure, or cardiac discomfort. The typical indications of AF are dizziness, confusion, fainting, or tiredness. Therapeutic advancements and the burgeoning aged populace also drive the industry. Supportive clinical
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Atrial Fibrillation Market Opportunity Analysis, 2018-2026
Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. Most episodes of atrial fibrillation have no symptoms or fewer symptoms such as intermittent heart palpitations, lightheadedness, fainting, chest pain, and shortness of breath. Atrial fibrillation is linked with an elevated risk of heart failure, stroke, and dementia. The disease is a kind of supraventricular tachycardia. Risk factors associated
Atrial Septal Defect Market Future Opportunities2017 - 2025
Global Atrial Septal Defect Market: Outlook Atrial septal defect is one of the most common congenital cardiac diseases and usually affects women more than men. It is characterized by a hole or defect in the interatrial septum that separates the heart’s two upper chambers, i.e., atria. The opening in the septum usually closes when the baby is born, but in few cases if the opening does not close, the hole
Atrial Fibrillation Market Analysis, Forecast, and Assessment 2026
Increasing prevalence of common diseases and conditions such as obesity, diabetes, hypertension, etc., are leading to the risk of various heart problems. Moreover, the rise in people suffering from high blood pressure, and valvular heart disease due to the rheumatic fever are some of the most common risk factors for atrial fibrillation. Along with the increasing number of people suffering from atrial fibrillation, especially among the geriatric population. There has